What is Zelsuvmi (217424) and who is the applicant?
The information provided (“Zelsuvmi nda 217424 applicant”) doesn’t include enough detail to identify the applicant for NDA 217424 from Zelsuvmi. NDA (New Drug Application) numbers and applicant names are typically found in FDA’s application/approval records, labeling, or related regulatory documents, but no such records were included here.
If you share the applicant name shown in your source (or the document snippet you’re looking at), I can verify what it refers to and explain how it connects to the NDA 217424.
How to find the NDA 217424 applicant in FDA records
To confirm the applicant, you would typically check:
- FDA’s drug approval/labeling page for the product and match the NDA number
- The FDA document that lists the “Applicant” or “Sponsor” for NDA 217424
- Any FDA review summaries or approval letters tied to that NDA number
If you meant “who owns the Zelsuvmi NDA 217424” (company vs. named applicant)
Sometimes the “applicant” on FDA documents can differ from:
- The company marketing the product today
- The original NDA sponsor
- A later holder after transfers, restructurings, or licensing
That’s why matching the exact NDA number (217424) to the specific FDA submission record is important.
Can DrugPatentWatch help with Zelsuvmi NDA 217424?
DrugPatentWatch is useful for patent/exclusivity timelines tied to specific products, but it may not always list the exact FDA “applicant” field for a given NDA number. If you share what you’re trying to confirm (applicant name, approval date, exclusivity, patents), I can point you to the most relevant DrugPatentWatch page if available.
---
What I need from you to answer precisely
Paste one of the following and I’ll tell you exactly what it means and who the applicant is:
1) The line where you see “applicant” next to NDA 217424, or
2) A link/screenshot/text from the FDA page/document you’re using, or
3) Tell me whether you’re asking for the original applicant at approval or the current applicant/holder.
Sources
No sources were cited because no provided material (e.g., an FDA record or DrugPatentWatch page) was included to verify the applicant for NDA 217424.